Publications by authors named "Luca Corti"

Claim this Profile
C
Chronic Obstructive Pulmonary Disease Case Finding: Severity Grade at First Spirometry and Ongoing Therapy 12 Months after Initial Diagnosis.
Manlio Milanese, Alessandro Cavaliere, Giovanni Cavallaro, Luca Corti, Alessandra Longagna

Respiration· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social media analysis of Twitter tweets related to ASD in 2019-2020, with particular attention to COVID-19: topic modelling and sentiment analysis.
Luca Corti, Michele Zanetti, Giovanni Tricella, Maurizio Bonati

J Big Data· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 'Is' and the 'Ought' of the Animal Organism: Hegel's Account of Biological Normativity.
Luca Corti

Hist Philos Life Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.
Maria Menichincheri, Elena Ardini, Paola Magnaghi, Nilla Avanzi, Patrizia Banfi, Luca Corti

J Med Chem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.
Maria Menichincheri, Elena Ardini, Paola Magnaghi, Nilla Avanzi, Patrizia Banfi, Luca Corti

J Med Chem· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effect.
Maurizio Pulici, Gabriella Traquandi, Chiara Marchionni, Michele Modugno, Rosita Lupi, Luca Corti

ChemMedChem· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minor head injury in the elderly at very low risk: a retrospective study of 6 years in an Emergency Department (ED).
Alessandro Riccardi, Flavio Frumento, Grazia Guiddo, Maria Beatrice Spinola, Luca Corti

Am J Emerg Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emergency physician and the prompt management of severe hyperkalemia.
Alessandro Riccardi, Franco Tasso, Luca Corti, Maria Panariello, Roberto Lerza

Intern Emerg Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Substituted pyrrolo[3,4-c]pyrazoles: an improved class of CDK2 inhibitors.
Maria Gabriella Brasca, Clara Albanese, Raffaella Amici, Dario Ballinari, Luca Corti

ChemMedChem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding.
Paolo Pevarello, Maria Gabriella Brasca, Raffaella Amici, Paolo Orsini, Gabriella Traquandi, Luca Corti

J Med Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis